Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APEX1 | P27695 | 1/20 | 0.48 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.37 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.37 |
| ▸ | GRIA1 | P42261 | 2/20 | 0.37 |
| ▸ | GRIA2 | P42262 | 2/20 | 0.37 |
| ▸ | GRIA3 | P42263 | 2/20 | 0.37 |
| ▸ | GRIA4 | P48058 | 2/20 | 0.37 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.37 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.37 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.37 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.37 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | STAT3 | P40763 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13629866 | 0.83 | PDE4A (0.36) | APEX1KDM4EALDH1A1 | |
| SCHEMBL5860460 | 0.81 | LMNA (0.49) | KDM4EALDH1A1HPGDMEN1KMT2A | |
| SCHEMBL490624 | 0.79 | — | — | |
| SCHEMBL667246 | 0.79 | KDM4E (0.54) | KDM4EALDH1A1KMT2A | |
| SCHEMBL294649 | 0.78 | PARP1 (0.36) | APEX1KDM4EALDH1A1HPGDMEN1 | |
| SCHEMBL4348692 | 0.77 | ADRA1D (0.37) | MEN1KMT2A | |
| SCHEMBL6537411 | 0.77 | KMO (0.36) | ALDH1A1GRIA1GRIA2GRIA3GRIA4 | |
| SCHEMBL5282402 | 0.75 | GRIA1 (0.51) | KDM4EALDH1A1MEN1KMT2AGRIA1 | |
| SCHEMBL16247195 | 0.75 | APAF1 (0.46) | KDM4EALDH1A1GRIA1 | |
| SCHEMBL2983409 | 0.74 | ADRA1D (0.34) | KDM4EALDH1A1HPGDMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 351 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0792283-A1 | SYNTHESIS OF PEPTIDE NUCLEIC ACIDS (PNAs) AND ANALOGUES VIA SUBMONOMER APPROACH | CHIRON CORPORATION (US) | 1997-09-03 | — | — | EP | claimed |
| WO-1996015143-A1 | SYNTHESIS OF PEPTIDE NUCLEIC ACIDS (PNAs) AND ANALOGUES VIA SUBMONOMER APPROACH | CHIRON CORPORATION (US) | 1996-05-23 | — | — | WO | claimed |
| WO-2024145451-A2 | METHODS FOR RESTORING REGENERATIVE POTENTIAL OF AGED LUNG ALVEOLI AND AGED ADULT STEM CELL COMPARTMENTS | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2024-07-04 | — | — | WO | disclosed |
| EP-4392454-A1 | ANTI-PSMA ANTIBODIES AND USES THEREOF | Janssen Biotech, Inc. (US) | 2024-07-03 | — | — | EP | disclosed |
| EP-4392081-A1 | ANTI-PSMA RADIOCONJUGATES AND USES THEREOF | Janssen Biotech, Inc. (US) | 2024-07-03 | — | — | EP | disclosed |
| WO-2024137873-A1 | QUANTIFICATION OF CO-LOCALIZED TAG SEQUENCES USING ORTHOGONAL SEQUENCE ENCODING | ULTIMA GENOMICS, INC. (US) | 2024-06-27 | — | — | WO | disclosed |
| EP-4380954-A1 | SARS-COV-2 VIRUS-LIKE PARTICLES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-06-12 | — | — | EP | disclosed |
| WO-2024102972-A1 | BASE EDITING OF TRANSTHYRETIN GENE | BEAM THERAPEUTICS INC. (US) | 2024-05-16 | — | — | WO | disclosed |
| WO-2024092216-A2 | METHODS AND COMPOSITIONS REGARDING MODULATION OF POULTRY GENES | OHIO STATE INNOVATION FOUNDATION (US) | 2024-05-02 | — | — | WO | disclosed |
| WO-2023250183-A2 | COMPOSITIONS AND METHODS FOR EPIGENETIC EDITING | CHROMA MEDICINE, INC. (US) | 2023-12-28 | — | — | WO | disclosed |
| WO-2023250148-A1 | COMPOSITIONS AND METHODS FOR EPIGENETIC EDITING | CHROMA MEDICINE, INC. (US) | 2023-12-28 | — | — | WO | disclosed |
| WO-2000002864-A1 | PRECUSORS FOR PNA-MONOMERS | MARTENS JUERGEN (DE) | 2000-01-20 | — | — | WO | disclosed |
| CN-1211255-A | Ob receptor and method of diagnosing and treating weight | MILLENNIUM PHARM INC (US) | 1999-03-17 | — | — | CN | disclosed |
| WO-1998046748-A1 | THERAPEUTIC COMPOSITIONS AND DIAGNOSTIC ASSAYS FOR DISEASES INVOLVING TRBP | MILLENNIUM PHARMACEUTICALS INC. (US) | 1998-10-22 | — | — | WO | disclosed |
| WO-1997046207-A2 | AROMATIC HETEROCYCLIC DERIVATIVES AS ENZYME INHIBITORS | CORVAS INTERNATIONAL, INC. (US) | 1997-12-11 | — | — | WO | disclosed |
| WO-1995019779-A1 | DELTEX PROTEINS, NUCLEIC ACIDS, AND ANTIBODIES, AND RELATED METHODS AND COMPOSITIONS | YALE UNIVERSITY (US) | 1995-07-27 | — | — | WO | disclosed |
| US-5213972-A | Production of thymidine and deoxyuridine, intermediates for AZT | CHEMGEN CORPORATION (US) | 1993-05-25 | — | — | US | disclosed |
| EP-0504279-A4 | FERMENTATION PROCESS FOR THE PRODUCTION OF PYRIMIDINE DEOXYRIBONUCLEOSIDES | — | 1993-02-17 | — | — | EP | disclosed |
| EP-0504279-A1 | FERMENTATION PROCESS FOR THE PRODUCTION OF PYRIMIDINE DEOXYRIBONUCLEOSIDES. | CHEMGEN CORP (US) | 1992-09-23 | — | — | EP | disclosed |
| WO-1991009130-A1 | FERMENTATION PROCESS FOR THE PRODUCTION OF PYRIMIDINE DEOXYRIBONUCLEOSIDES | CHEMGEN CORPORATION (US) | 1991-06-27 | — | — | WO | disclosed |